Norges Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $181M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $124M | Buy |
|
|||||
|
2024
Q3 | $136M | Hold |
|
|||||
|
2024
Q2 | $127M | Buy |
|
|||||
|
2024
Q1 | $137M | Buy |
|
|||||
|
2023
Q4 | $120M | Buy |
|
|||||
|
2023
Q3 | $112M | Buy |
|
|||||
|
2023
Q2 | $126M | Sell |
|
|||||
|
2023
Q1 | $157M | Buy |
|
|||||
|
2022
Q4 | $151M | Buy |
|
|||||
|
2022
Q3 | $141M | Buy |
|
|||||
|
2022
Q2 | $143M | Buy |
|
|||||
|
2022
Q1 | $120M | Buy |
|
|||||
|
2021
Q4 | $118M | Buy |
|
|||||
|
2021
Q3 | $103M | Buy |
|
|||||
|
2021
Q2 | $115M | Buy |
|
|||||
|
2021
Q1 | $121M | Buy |
|
|||||
|
2020
Q4 | $51.2M | Buy |
|
|||||
|
2020
Q3 | $30.4M | Sell |
|
|||||
|
2020
Q2 | $112M | Buy |
|